Picture of Eutilex Co logo

263050 Eutilex Co Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual income statement for Eutilex Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue73.52161329,52710,295
Cost of Revenue
Gross Profit625405
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses33,63334,36729,83539,36635,926
Operating Profit-33,560-34,151-29,703-29,839-25,631
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-29,575-34,470-28,342-29,558-25,759
Provision for Income Taxes
Net Income After Taxes-29,575-34,470-28,342-29,499-25,791
Minority Interest
Net Income Before Extraordinary Items
Net Income-29,893-33,427-27,718-29,166-23,924
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-29,893-33,427-27,718-29,166-23,924
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1,110-1,188-756-734-531
Dividends per Share